Pharmsynthez Ratios and Metrics

Market cap in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Jul '22 Jul 7, 2022	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,356	-	1,984	1,356	1,689	2,062
Market Cap Growth	-	-	46.30%	-19.70%	-18.10%	65.06%
Enterprise Value	2,049	-	2,488	1,956	2,326	2,106
Last Close Price	4.50	-	4.50	4.50	5.61	6.64
PE Ratio	-	-	7.80	-	-	-
PS Ratio	8.81	-	8.02	3.57	3.85	5.55
PB Ratio	0.76	-	0.96	11.20	4.89	2.03
P/TBV Ratio	0.87	-	1.07	-	209.80	3.10
EV/Sales Ratio	13.31	-	10.06	5.15	5.31	5.67
Debt / Equity Ratio	0.22	0.20	0.18	6.16	2.05	0.62
Net Debt / Equity Ratio	0.22	0.20	0.17	6.08	2.01	0.61
Net Debt / EBITDA Ratio	-2.88	-2.53	-1.36	-6.94	-3.53	-5.95
Net Debt / FCF Ratio	-	-	-	-107.90	-11.00	-2.53
Asset Turnover	0.06	0.06	-	0.28	0.25	0.17
Inventory Turnover	1.53	1.85	-	7.56	5.31	2.88
Quick Ratio	0.21	0.20	0.32	0.07	0.09	0.24
Current Ratio	0.29	0.29	0.44	0.17	0.21	0.45
Return on Equity (ROE)	-11.45%	-13.09%	-	-88.98%	-102.63%	-44.13%
Return on Assets (ROA)	-3.63%	-3.77%	-	-5.70%	-8.18%	-4.11%
Return on Capital Employed (ROCE)	-9.10%	-9.40%	-14.50%	-77.30%	-52.70%	-14.30%
Earnings Yield	-15.91%	-	12.82%	-15.30%	-41.31%	-25.45%
FCF Yield	-	-	-	-0.50%	-3.73%	-11.76%
Buyback Yield / Dilution	-1.23%	-	-46.30%	-	-	-